201 related articles for article (PubMed ID: 25674007)
21. Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells.
Tian J; Raffa FA; Dai M; Moamer A; Khadang B; Hachim IY; Bakdounes K; Ali S; Jean-Claude B; Lebrun JJ
Br J Cancer; 2018 Dec; 119(12):1495-1507. PubMed ID: 30482914
[TBL] [Abstract][Full Text] [Related]
22. Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and
Hermawan A; Ikawati M; Jenie RI; Khumaira A; Putri H; Nurhayati IP; Angraini SM; Muflikhasari HA
Saudi Pharm J; 2021 Jan; 29(1):12-26. PubMed ID: 33603536
[TBL] [Abstract][Full Text] [Related]
23. Umbilical cord blood-derived CD11c(+) dendritic cells could serve as an alternative allogeneic source of dendritic cells for cancer immunotherapy.
Kumar J; Kale V; Limaye L
Stem Cell Res Ther; 2015 Sep; 6():184. PubMed ID: 26407613
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation.
Aldinucci A; Rizzetto L; Pieri L; Nosi D; Romagnoli P; Biagioli T; Mazzanti B; Saccardi R; Beltrame L; Massacesi L; Cavalieri D; Ballerini C
J Immunol; 2010 Nov; 185(9):5102-10. PubMed ID: 20889545
[TBL] [Abstract][Full Text] [Related]
25. The effects and mechanisms of SLC34A2 on maintaining stem cell-like phenotypes in CD147
Lv Y; Wang T; Fan J; Zhang Z; Zhang J; Xu C; Li Y; Zhao G; He C; Meng H; Yang H; Wang Z; Liu J; Chen J; Wang L
Tumour Biol; 2017 Apr; 39(4):1010428317695927. PubMed ID: 28381172
[TBL] [Abstract][Full Text] [Related]
26. [Induction of active antitumor immune response by myeloma idiotype protein-pulsed dendritic cells].
Yin XR; Zhang M; Luo YY; Lin X; He PC; Chen LM; Cai RB; Guo GL
Ai Zheng; 2005 Jun; 24(6):657-62. PubMed ID: 15946473
[TBL] [Abstract][Full Text] [Related]
27. Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells.
Zhao ZG; Xu W; Sun L; You Y; Li F; Li QB; Zou P
Immunol Invest; 2012; 41(2):183-98. PubMed ID: 21936678
[TBL] [Abstract][Full Text] [Related]
28. Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.
Yeo SK; Wen J; Chen S; Guan JL
Cancer Res; 2016 Jun; 76(11):3397-410. PubMed ID: 27197172
[TBL] [Abstract][Full Text] [Related]
29. [NVP-BKM120 in combination with letrozole inhibit human breast cancer stem cells via PI3K/mTOR pathway].
Liu Y; Zhang XB; Liu JJ; Zhang S; Zhang J
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(14):1075-1080. PubMed ID: 30982255
[No Abstract] [Full Text] [Related]
30. Hybrid nanoparticles coated with hyaluronic acid lipoid for targeted co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
Yang Z; Sun N; Cheng R; Zhao C; Liu J; Tian Z
J Mater Chem B; 2017 Sep; 5(33):6762-6775. PubMed ID: 32264326
[TBL] [Abstract][Full Text] [Related]
31. Bone Marrow Mesenchymal Stem Cells Inhibit the Function of Dendritic Cells by Secreting Galectin-1.
Zhang Y; Ge XH; Guo XJ; Guan SB; Li XM; Gu W; Xu WG
Biomed Res Int; 2017; 2017():3248605. PubMed ID: 28713822
[TBL] [Abstract][Full Text] [Related]
32. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
33. EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models.
Giró-Perafita A; Rabionet M; Planas M; Feliu L; Ciurana J; Ruiz-Martínez S; Puig T
Molecules; 2019 Mar; 24(6):. PubMed ID: 30875891
[TBL] [Abstract][Full Text] [Related]
34. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells.
Gao WX; Sun YQ; Shi J; Li CL; Fang SB; Wang D; Deng XQ; Wen W; Fu QL
Stem Cell Res Ther; 2017 Mar; 8(1):48. PubMed ID: 28253916
[TBL] [Abstract][Full Text] [Related]
35. [The effect of co-transplantation of bone marrow-derived mesenchymal stem cells and islet on maturation and function of bone marrow-derived dendritic cells in recipient mice].
Li FR; Deng CY; Wang XG; Qi H; Ren LL; Zhou HX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):646-9. PubMed ID: 20619087
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
37. OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-Resistant Breast Cancer Mice.
Peng W; Chang L; Li W; Liu Y; Zhang M
Front Oncol; 2022; 12():781093. PubMed ID: 35402219
[TBL] [Abstract][Full Text] [Related]
38. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of neural stem cells derived from human embryonic stem cells on differentiation and function of monocyte-derived dendritic cells.
Shahbazi M; Kwang TW; Purwanti YI; Fan W; Wang S
J Neurol Sci; 2013 Jul; 330(1-2):85-93. PubMed ID: 23664653
[TBL] [Abstract][Full Text] [Related]
40. [Inducing hepatocellular carcinoma-specific cytotoxic T lymphocyte response using formed by fusion of FastDCs and allogeneic human hepatocellular carcinoma cells].
Guan X; Leng XS; Peng JR; Wei YH; Wang H; Yuan L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3332-6. PubMed ID: 16409838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
